A quantitative model to evaluate solubility relationship of polymorphs from their thermal properties

Pharmaceutical Research

Volumn 22, Issue 7, 2005, Pages 1149-1157

  Mao, Chen ^a   Pinal, Rodolfo ^a   Morris, Kenneth R ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Flufenamic acid; Model; Polymorphs; Solubility; Thermal properties

Indexed keywords

FLUFENAMIC ACID;

ANALYTIC METHOD; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; ENANTIOMER; GLASS TRANSITION TEMPERATURE; HEAT TREATMENT; MELTING POINT; PHASE TRANSITION; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLUBILITY; THERMAL ANALYSIS; THERMODYNAMICS;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; FLUFENAMIC ACID; HEAT; MODELS, CHEMICAL; SOLUBILITY; THERMODYNAMICS; TRANSITION TEMPERATURE;

EID: 23744437712     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-005-5363-8     Document Type: Article

References (18)

1. S. R. Byrn R. R. Pfeiffer J. G. Stowell 1999 Solid-State Chemistry of Drugs SSCI Inc. West Lafayette, IN
2. A. A. Noyes W. R. Whitney 1897 The rate of solution of solid substances in their own solutions J. Am. Chem. Soc. 19 930 934
3. T. T. Higuchi D. J. W. Grant 1990 Solubility Behavior of Organic Compounds John Wiley and Sons New York 22 36
4. C.-H. Gu D. J. W. Grant 2001 Estimating the relative stability of polymorphs and hydrates from heats of solution and solubility data J. Pharm. Sci. 90 1277 1287
5. L. Yu 1995 Inferring thermodynamic stability relationship of polymorphs from melting data J. Pharm. Sci. 84 966 974
6. S. H. Yalkowsky S. Banerjee 1992 Aqueous Solubility: Methods of Estimation for Organic Compounds Marcel Dekker New York
7. A. Burger R. Ramberger 1979 On the polymorphism of pharmaceuticals and other molecular crystals. I Mikrochim. Acta (Wien) 2 259 271
8. E. V. Boldyreva V. A. Drebushchak I. E. Paukov Y. K. Kovalevskaya T. N. Drebushchak 2004 DSC and adiabatic calorimetry study of the polymorphs of paracetamol, an old problem revisited J. Therm. Anal. Calorim. 77 607 623
9. G. Defossemont S. L. Randzio B. Legendre 2004 Contributions of calorimetry for Cp determination and of scanning transitiometry for the study of polymorphism Cryst. Growth Des. 4 1169 1174
10. R. J. Behme D. Brooke 1991 Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis J. Pharm. Sci. 80 986 990
11. 2S), their thermal analyses and structural comparison Acta Crystallogr. B48 492 498
12. B. Legendre Y. Feutelais 2004 Polymorphic and thermodynamic study of indomethacin J. Therm. Anal. Calorim. 76 255 264
13. B. C. Hancock M. Parks 2000 What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17 397 404
14. S. Ghodbane J. A. McCauley 1990 Study of the polymorphism of 3-(((3-(2-(7-chloro-2-quinolinyl)-(E)-ethenyl)phenyl) ((3-(dimethylamino-3- oxopropyl) thio) methyl)-thio) propanoic acid (MK571) by DSC, TG, XRPD and solubility measurements Int. J. Pharm. 59 281 286
15. A. Burger A. Lettenbichler 2000 Polymorphism and preformulation studies of lifibrol Eur. J. Pharm. Biopharm. 49 65 72
16. A. Burger R. Ramberger 1980 Thermodynamic relationships between polymorphic modifications-flufenamic acid and mefenamic acid Mikrochim. Acta. 1 17 28 (in German)
17. S. Romero B. Escalera P. Bustamante 1999 Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures Int. J. Pharm. 178 193 202
18. M. Kanke K. Sekiguchi 1973 Dissolution behavior of solid drugs II. Determination of the transition temperature of sulfathiazole polymorphs by measuring the initial rates Chem. Pharm. Bull. 21 878 884